Contacts

Doctor Andy Poumbourios

Co-Head, Viral Entry and Vaccines Group

Background

Dr. Andy Poumbourios is co-Head of the Viral Entry and Vaccines research group at Burnet Institute and the lead of the SARS-CoV-2 stream of the Burnet Vaccine Initiative. His career has followed an interest in the therapeutic and immunogenic potential of viral envelope proteins that mediate cellular entry.

With a focus on understanding how the Spike proteins of HIV-1, human T cell leukemia virus and hepatitis C virus perform their functions and how this relates to their structures, Andy has applied this knowledge to the development of Burnet hepatitis C vaccine, publishing and patenting its development over the last decade. This knowledge has now facilitated the discovery of the Burnet vaccine candidate for SARS-CoV-2, which in turn brought about the formation of the Burnet Vaccine Initiative.

Andy has won multiple NHMRC grants and holds granted patents.

Projects (6)

Current (5)

  • Burnet COVID-19 Vaccine | Burnet Vaccine Initiative (BVI)

  • COVID-19 Vaccine Development

  • Development of a universal prophylactic vaccine for Hepatitis C

  • HepSeeVax: Proof-of-concept study of an HCV vaccine candidate

  • Neutralising antibody assays for COVID-19

Publications (57)

2022 (2)

2021 (1)

2020 (2)

2019 (1)

2018 (2)

2017 (2)

2015 (2)

2013 (2)

2012 (2)

2011 (3)

2010 (2)

2009 (1)

2007 (5)

2006 (2)

2005 (2)

2004 (2)

2003 (3)

2002 (2)

2001 (2)

2000 (1)

1999 (2)

1998 (3)

1997 (2)

1995 (2)

1993 (1)

1992 (1)

1991 (2)

1990 (1)

1988 (1)

1987 (1)

News Articles (13)

2022 (2)

2021 (1)

2020 (1)

2019 (2)

2018 (3)

2016 (3)

2013 (1)